Gastric Bypass Companies

Intuitive Surgical (US) Saw a drop in bariatric procedure share due to competition from weight-loss drugs but predicts a rebound in 2024 as patients seeking surgery reschedule procedures. The company also recently received Japanese Ministry of Health approval for its da Vinci SP surgical system, potentially expanding its reach in bariatric surgery.

Medtronic (US) Downplayed the impact of weight-loss drugs on its bariatric surgery business, expecting negligible impact on its cardiovascular procedures and a potential increase in new patients considering surgery after a short-term drug phase.

Apollo Endosurgery Acquired by Boston Scientific Corporation (US) in November 2022, bringing its specialized stapling technology for bariatric procedures into the Boston Scientific portfolio, potentially enhancing product offerings and market reach.

Standard Bariatrics (US) Acquired by Teleflex Incorporated (US) in September 2022, adding its innovative powered stapling technology to Teleflex's portfolio, strengthening its presence in the bariatric surgery market.

William Blair (US) Conducted a survey of bariatric surgeons, indicating the potential for weight-loss drugs to lead to an increase in new patients considering gastric bypass after a short-term drug phase, supporting Intuitive Surgical's prediction of a market rebound

List of Gastric Bypass Key Companies in the Market

• Medtronic (U.S.)


• Intuitive Surgical Inc. (U.S.)


• TransEnterix Inc. (U.S.)


• ALLERGAN (Republic of Ireland)


• USGI Medical Inc. (U.S.)


• Cousin Biotech (France)


• GI Dynamics Inc. (U.S.)


• Johnson & Johnson Services Inc. (U.S.)


• Mediflex Surgical Product (U.S.)